Form 483 · FEI 3018078670

Form 483 issued November 6, 2024 · Washington, District of Columbia

Inspection
Nov 4 – Nov 6, 2024
Investigator
Tiki Dixon
Observations
4
Pages
4
FEI number
3018078670

In short: On November 6, 2024, FDA issued a Form 483 with 4 observations to an FDA-inspected site in Washington, District of Columbia (FEI 3018078670) after an inspection that ran Nov 4 – Nov 6, 2024. The investigator was Tiki Dixon. Most observations concern production & process controls and management controls.

At a glance

Production & process controls and management controls account for 4 of 4 observations.

Production & process controls2
Management controls2

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for acceptance activities have…

  2. 02

    Software used as part of production and the quality system has not been adequately validated for…

  3. 03

    Procedures for management review have…

  4. 04

    Procedures for quality audits have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at an FDA-inspected site?

FDA listed 4 observations on this Form 483, mostly about production & process controls and management controls. The opening words of each observation are shown on this page.

Who inspected an FDA-inspected site?

Tiki Dixon is named on this Form 483, for the inspection of Nov 4 – Nov 6, 2024. Each investigator has a profile showing what they cite most.

When was an FDA-inspected site inspected by FDA?

The inspection ran Nov 4 – Nov 6, 2024, and the Form 483 is dated November 6, 2024.

How do I get the full Form 483 for an FDA-inspected site?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free